Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 2 (NPM1P2)

Target
NPM1P2
Molecular classification
Other (Pseudogene)
01

Overview

Nucleophosmin 1 pseudogene 2 (NPM1P2, also called NG2-6) is a non-coding pseudogene related to the nucleophosmin 1 (NPM1) gene. Pseudogenes are DNA segments similar to known genes but typically lack the ability to encode functional proteins due to mutations, truncations, or loss of regulatory elements. There are no known biological functions, molecular interactions, disease associations, or drug interactions described for NPM1P2. This gene should not be confused with the protein-coding NPM1 gene, which encodes the nucleolar protein nucleophosmin involved in ribosome biogenesis, cell proliferation, and cancer biology[1][4][7]. Similarly, "NG2" often refers to the chondroitin sulfate proteoglycan 4 (CSPG4), a distinct glial and stem cell marker unrelated to NPM1 pseudogenes[2]. The use of "NPM1P2" or "NG2-6" as a target is incorrect and does not map to any established therapeutic, diagnostic, or biological target. If you are seeking information about **NPM1** (nucleophosmin 1, sometimes confused with pseudogenes), that is a well-characterized multifunctional protein implicated in several essential cellular and disease processes, including cancer[1][4][7]. However, NPM1P2 itself is not functionally characterized and is not an accepted drug target.

Other names
NG2-6nucleophosmin pseudogene 2

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 2 (NPM1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 2 (NPM1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call